Ole Andreas Halvorsen's Net Worth

$2.18 Billion

Who is Ole Andreas Halvorsen?

Ole Andreas Halvorsen has an estimated net worth of $2.18 Billion. This is based on reported shares across multiple companies, which include Adaptive Biotechnologies Corp, Roivant Sciences Ltd., Wayfair Inc., Urovant Sciences Ltd., Myovant Sciences Ltd., FIRST DATA CORP, Arbutus Biopharma Corp, APi Group Corp, Axovant Gene Therapies Ltd., BridgeBio Pharma, Inc., Amylyx Pharmaceuticals, Inc., Zentalis Pharmaceuticals, Inc., RayzeBio, Inc., Editas Medicine, Inc., Inhibrx, Inc., PROCEPT BioRobotics Corp, 4D Molecular Therapeutics, Inc., Rallybio Corp, Ginkgo Bioworks Holdings, Inc., FIGS, Inc., and Frazier Lifesciences Acquisition Corp.

SEC CIK

Ole Andreas Halvorsen's CIK is 0001133006

Past Insider Trading and Trends

2019 was Ole Andreas Halvorsen's most active year for acquiring shares with 72 total transactions. Ole Andreas Halvorsen's most active month to acquire stocks was the month of May. 2022 was Ole Andreas Halvorsen's most active year for disposing of shares, totalling 22 transactions. Ole Andreas Halvorsen's most active month to dispose stocks was the month of August. 2022 saw Ole Andreas Halvorsen paying a total of $312,238,236.29 for 300,884,319 shares, this is the most they've acquired in one year. In 2020 Ole Andreas Halvorsen cashed out on 19,163,712 shares for a total of $573,887,078.58, their largest year based on trade value.